Abstract. Regulator of G protein signaling (RGS) proteins are responsible for the rapid turnoff of G protein-coupled receptor signaling pathways. RGS9-2, a brain-specific splice variant of the RGS9 gene, is highly expressed in the striatum but lowly expressed in the periaqueductal gray and spinal cord, which mediate various actions of morphine and other opiates. In order to identify the markers that contribute to the genetic susceptibility of heroin dependence, the potential association between heroin dependence and 10 single nucleotide polymorphisms (SNPs), including rs8077696, rs8070231, rs2292593, rs2292592, rs9916525, rs1122079, rs4790953, rs1530351, rs4791230 and rs2869577 of the RGS9 gene was evaluated using the MassARRAY system. The present study recruited 425 heroin-dependent patients and 205 healthy controls. The results revealed that two SNPs (rs1530351 and rs4791230) located in the promoter region of the RGS9 gene, were significantly associated with heroin dependence (P<0.05). The frequency of the C allele in rs1530351 (χ 2 =8.031, P=0.005, OR=2.079, 95% CI=1.241-3.483) and the G allele in rs4791230 (χ 2 =7.360, P=0.007, OR=2.021, 95% CI=1.205-3.389) in the heroin-dependent patients was significantly higher than that in the controls. Furthermore, linkage disequilibrium was observed in three blocks (D'>0.9) and significantly less T-A haplotypes (χ 2 =4.867, P=0.027, OR=0.442, 95% CI=0.210-0.929) were identified in the heroin-dependent patients, suggesting that they may exhibit protective effects against heroin dependence.
Introduction
Drug dependence, generally defined as compulsive drug use and loss of control over drug intake, is induced by repeated exposure to substances, including opioids and psychostimulants (1, 2) . A previous study demonstrated that there is a genetic component for the risk of substance dependence, particularly opioid dependence (3) . Consistently, family and twin studies have demonstrated a substantial genetic effect on the development of drug dependence, with inherited risk estimates in the range of 40-60% (4, 5) . A previous study revealed that the regulator of G protein signaling 9 (RGS9) gene may be associated with drug dependence, including opiate dependence (6) .
Human and animal studies revealed that the D2-like dopamine receptors are critical in the development of substance dependence (7, 8) . The heterotrimeric G protein system regulates the activity of the dopamine receptors. RGS regulates the function of heterotrimeric G protein in part by stimulating the GTPase activity of the G protein subunits (9, 10) . RGS9, a member of the RGS family, has two splice isoforms (9, 10) . The short splice isoform RGS9-1, which contains 18 amino acid residues at the C-terminus is expressed in the photoreceptors of the retina. In the long splice isoform, RGS9-2, the short C-terminus is replaced by a longer region of 209 amino acids (11) . RGS9-2 is specifically expressed in the striatum important for opiate reward, but is lowly expressed in the periaqueductal gray and spinal cord important for opiate analgesia (12) . Therefore, RGS9-2 has been regarded as a potential partner for G protein-coupled receptors involved in drug dependence, including morphine (12) (13) (14) .
The RGS9 gene (17q21-25, 1.1 Mb) has 18 exons with intron-exon junctions conforming to splice-site consensus sequences (15) . Linkage studies demonstrated that the region was implicated in susceptibility to major mental illness (16) (17) (18) (19) 3'-flanking region of the RGS9 gene was reported to be weakly associated with antipsychotic-induced tardive dyskinesia in a Chinese population in Taiwan (17) . However, to the best of our knowledge, the association between the RGS9 gene and heroin dependence has not yet been investigated. In view of the crucial role of RGS9 in heroin dependence, the present study investigated 10 SNPs (rs8077696, rs8070231, rs2292593, rs2292592, rs9916525, rs1122079, rs4790953, rs1530351, rs4791230 and rs2869577) in a Chinese population to verify the putative association between RGS9 polymorphisms and heroin dependence. Table I . Preliminary analysis was performed using the HapMap data (http://www.ncbi.nlm. nih.gov/SNP/snp). Tag SNPs were examined with Haploview software version 4.2 (Broad Institute, Cambridge, MA, USA) using the Chinese Han in Beijing population and a minor allele frequency cut-off ≥5% (HapMap Data Release 27). The linkage disequilibrium (LD) pattern of this gene was determined in the Chinese population using the preliminary data from the HapMap. These SNPs were further analyzed in an association study.
Subjects and methods

Subjects
Between 3-5 ml of peripheral blood were collected in tubes coated with EDTA. Genomic DNA was extracted from blood leukocytes using the EZNA™ Blood DNA Midi kit (Omega Bio-Tek, Norcross, GA, USA), according to the manufacturer's instructions. DNA was stored at -80˚C for SNP analysis. Cases and controls were mixed on the same plates and a double-blind procedure was performed. Probes and primers were designed using the Assay Design software version 3.4 (Sequenom Inc., San Diego, CA, USA) (Table II) . SNP genotyping was performed using matrix assisted laser desorption ionization-time of flight mass spectrometry (MassARRAY system; Sequenom Inc.). Genotype calling was performed in real time using the MassARRAY RT software version 3.0.0.4 and data analysis was performed using the MassARRAY Typer software (version 3.4; Sequenom Inc.).
Statistical analysis. All statistical tests were conducted with SPSS 16.0 for Windows (SPSS, Inc., Chicago, IL, USA). The Hardy-Weinberg equilibrium (HWE) for each SNP was assessed using the Genepop v4.0 (19) . Associations between the case-control status and each polymorphism were assessed by Fisher's exact test or Pearson's χ 2 test. The odds ratio (OR) and 95% confidence interval (CI) were used to measure the strength of the association between allele frequencies and the RGS9 gene. The Bonferroni correction was used to adjust the test level when multiple comparisons were conducted and the P-value was divided by the total number of loci or haplotypes. Pair-wise LD statistics (D' and r 2 ) and haplotype frequencies were computed using Haploview 4.0 to construct haplotype blocks. All P values presented were two sided, and P<0.05 was considered to indicate a statistically significant difference.
Results
The distribution frequencies of the 10 genotyped SNPs were in agreement with the HWE. The analysis of linkage disequilibrium in the heroin-dependent patients and the healthy controls revealed that two SNPs were located in haplotype block 1 (rs1530351 and rs4791230), four SNPs were located in haplotype block 2 (rs8077696, rs8070231, rs2869577 and rs2292593) and four SNPs were located in haplotype block 3 (rs2292592, rs9916525, rs1122079 and rs4790953; D'>0.9; Fig. 1 ). The genotype distribution, allelic frequencies and haplotypes in the heroin-dependent patients and the healthy controls are shown in Tables I and III-V. The results demonstrated that there were significant differences in the genotype frequency and allele frequency distribution of two SNPs (rs1530351 and rs4791230) between the heroin-dependent patients and the healthy controls. The frequency of the rs1530351 C allele was significantly higher in the heroin-dependent patients than in the healthy controls (χ 2 =8.031, P=0.005, OR=2.079, 95% CI=1.241-3.483). Compared with the healthy controls, the heroin-dependent patients carried a higher frequency of the rs4791230G allele (χ 2 =7.360, P=0.007, OR=2.021, 95%CI=1.205-3.389), whereas the remaining eight RGS9 SNPs exhibited negative results (Table I) .
Furthermore, LD was observed in three blocks (D'>0.9) and significantly less T-A haplotypes (χ 2 =4.867, P=0.027, OR=0.442, 95% CI=0.210-0.929) were identified in the heroin-dependent patients, suggesting that they may exhibit protective effects against heroin dependence, however, it did not pass the threshold value (P= 0.025).
Discussion
RGS9 is a member of the RGS family of proteins and is specifically expressed in the striatum, which is involved in movement, motivation, mood and dependence (14, 20) . Previous studies have demonstrated that acute morphine administration increases the expression of RGS9-2 in the nucleus accumbens and other CNS regions, whereas chronic administration decreases its expression (12) (13) (14) . Mice lacking RGS9 exhibit enhanced behavioral responses to acute and chronic morphine administration, including a significant increase in morphine reward, increased morphine analgesia with delayed tolerance and exacerbated morphine physical dependence and withdrawal (6) . This suggests that RGS9 acts upon the reward system of the brain, which is important in opiate dependence. Accumulated evidence indicates that RGS9 receptors are pivotal in the development of tolerance and physical dependence to opiates (6) . These findings establish RGS9 as a potent negative modulator of opiate action in vivo and suggest that opiate-induced alterations in the level of RGS9 contribute to the behavioral and neural plasticity associated with chronic opiate administration (6) . To the best of our knowledge, the present results provide the first direct evidence that a genetic change in the RGS9 gene is associated with heroin dependence in humans.
In the present study, significant differences were identified in the genotype frequency and allele frequency distribution of two SNPs (rs1530351 and rs4791230) in the promoter region between the heroin-dependent patients and the healthy controls. It was found that one SNP (rs1530351) in the RGS9 gene was significantly associated with increased risk of heroin dependence and another SNP (rs4791230) was also associated with increased risk of heroin dependence. To the best of our knowledge, this is the first study demonstrating a significant association between the RGS9 rs1530351 and rs4791230 SNPs with heroin dependence. A study confirmed that SNPs in the promoter region could alter microRNA binding to the promoter, resulting in the regulation of mRNA expression (21) . These studies suggested that the RGS9 gene may contribute to the susceptibility to psychotic diseases. The SNPs in the promoter of the RGS9 gene affected mRNA stability and regulated mRNA expression (21) , thereby affecting the genetic susceptibility to heroin dependence. Nevertheless, the role of the two SNPs in the genetic susceptibility to heroin dependence requires further investigation.
The genetic interactions among polymorphisms was further investigated and strong LD was observed. Haplotype analysis revealed that significantly less T-A haplotypes were identified in the heroin-dependent patients, although it did not pass the threshold value (P= 0.025). There were significant point-wise associations of these variants with heroin dependence. These results indicated that the patients with T-A haplotypes of the RGS9 gene were less prone to heroin dependence, suggesting that they may exhibit protective effects against heroin dependence. Further studies are required to examine the protective effect of the T-A haplotypes of the RGS9 gene on the risk of heroin dependence. Table III . RGS9 haplotypes in block 1 frequencies and the results of their associations with the risk of heroin dependence. Table IV . RGS9 haplotypes in block 2 frequencies and the results of their associations with the risk of heroin dependence. ------------------------------------------------------------------------- Table V . RGS9 haplotypes in block 3 frequencies and the results of their associations with the risk of heroin dependence. Haplotypes with a frequency <0.05 were excluded. b P-values were adjusted by Bonferroni correction and statistically significant results were identified (P<0.0125). OR, odds ratio; CI, confidence interval.
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In conclusion, the present study identified a strong association between two SNPs (rs1530351 and rs4791230) in the RGS9 gene and heroin dependence. These findings encourage future efforts in searching for functional polymorphisms within and close to the RGS9 gene using a systemic approach in a larger sample population.
